Fava, M., Freeman, M., Flynn, M., Judge, H., Hoeppner, B., & Cusin, C. et al. (2018). Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry, 25(7), 1592-1603. https://doi.org/10.1038/s41380-018-0256-5